A project led by Cornell's Center for Point of Care Technologies for Nutrition, Infection and Cancer (PORTENT) to develop a low-cost, battery-powered ...

About BioNexus Gene Lab Corp. BioNexus Gene Lab Corp. (Nasdaq: BGLC) is a precision diagnostics company focused on Southeast Asia. BGLC operates laboratories and partnerships across the region and is ...

Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...

SAGA Diagnostics, a pioneer in blood-based cancer detection and precision medicine redefining the standard for ultra-sensitive and early molecular residual disease (MRD) detection, will present five ...

AI is not limited to diagnostics or imaging. It also plays a transformative role in biomedical research, computational modeling, genomics and drug development. The authors highlight how ...

Ensuring blood safety remains one of the most effective defenses against transfusion-transmitted infections. By enhancing screening accuracy and enabling laboratories to detect HBV, HCV, HIV-1, and ...

The two neurodegenerative diseases could not appear more different. Amyotrophic lateral sclerosis (ALS), sometimes called Lou ...

Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

DELRAY BEACH, Fla., Nov. 25, 2025 /PRNewswire/ -- The global Veterinary Reference Laboratory Market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at ...

Abbott's $23B Exact Sciences deal adds short-term risk and earnings dilution. Click here to read what this means for ABT ...

Abbott is moving to acquire Exact Sciences, a molecular diagnostics company that specializes in the detection of early-stage ...